A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

PHASE3RecruitingINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

January 15, 2027

Study Completion Date

January 15, 2027

Conditions
Asthma
Interventions
DRUG

FF/UMEC/VI

FF/UMEC/VI will be administered.

DEVICE

ELLIPTA

FF/UMEC/VI and FF/VI will be administered via ELLIPTA inhaler

DRUG

FF/VI

FF/VI will be administered.

Trial Locations (42)

1757

WITHDRAWN

GSK Investigational Site, Seoul

2000

RECRUITING

GSK Investigational Site, Rosario

2447

RECRUITING

GSK Investigational Site, Seoul

4101

RECRUITING

GSK Investigational Site, South Brisbane

5018

RECRUITING

GSK Investigational Site, Ebdentown

6027

RECRUITING

GSK Investigational Site, Joondalup WA

10461

RECRUITING

GSK Investigational Site, The Bronx

28644

RECRUITING

GSK Investigational Site, Cheongju Chungcheongbuk-do

29420

RECRUITING

GSK Investigational Site, Charleston

31406

COMPLETED

GSK Investigational Site, Savannah

33165

RECRUITING

GSK Investigational Site, Miami

33173

COMPLETED

GSK Investigational Site, Miami

33174

RECRUITING

GSK Investigational Site, Miami

33180

COMPLETED

GSK Investigational Site, Aventura

35209

RECRUITING

GSK Investigational Site, Birmingham

36608

RECRUITING

GSK Investigational Site, Mobile

42301

RECRUITING

GSK Investigational Site, Owensboro

44106

RECRUITING

GSK Investigational Site, Cleveland

45229

RECRUITING

GSK Investigational Site, Cincinnati

45404

COMPLETED

GSK Investigational Site, Dayton

59808

RECRUITING

GSK Investigational Site, Missoula

61761

RECRUITING

GSK Investigational Site, Normal

65203

COMPLETED

GSK Investigational Site, Columbia

73120

RECRUITING

GSK Investigational Site, Oklahoma City

75034

COMPLETED

GSK Investigational Site, Plano

76712

COMPLETED

GSK Investigational Site, Waco

78028

RECRUITING

GSK Investigational Site, Kerrville

80909

RECRUITING

GSK Investigational Site, Colorado Springs

85253

RECRUITING

GSK Investigational Site, Paradise Valley

90274

COMPLETED

GSK Investigational Site, Rolling Hills Estates

92647

WITHDRAWN

GSK Investigational Site, Huntington Beach

92691

RECRUITING

GSK Investigational Site, Mission Viejo

93301

RECRUITING

GSK Investigational Site, Bakersfield

94598

WITHDRAWN

GSK Investigational Site, Walnut Creek

8320000

RECRUITING

GSK Investigational Site, Santiago

75225-6301

RECRUITING

GSK Investigational Site, Dallas

C1023AAB

RECRUITING

GSK Investigational Site, Buenos Aires

C1425BEN

RECRUITING

GSK Investigational Site, Buenos Aires

T4000IHE

RECRUITING

GSK Investigational Site, San Miguel de Tucumán

501-757

WITHDRAWN

GSK Investigational Site, Gwangju

03722

COMPLETED

GSK Investigational Site, Seoul

05505

RECRUITING

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT05757102 - A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma | Biotech Hunter | Biotech Hunter